Immutep Limited

Ticker IMMP

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Sydney, Australia

Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders.

Visit website

REPORT RATINGS

4.8 / 5.0 (132)

Immutep Limited reports have an aggregate usefulness score of 4.8 based on 132 reviews.

Immutep Limited